Background: The COVID-19 vaccinations have reignited optimism in many cultures devastated by the pandemic's tremendous loss of lives and livelihoods. Vaccination hesitancy is a critical and growing international problem in the global effort to manage the COVID-19 pandemic. To successfully handle vaccination hesitancy concerns, it is necessary to understand the levels of knowledge, attitudes, and behaviors on COVID-19. The purpose of this study was to understand people’s knowledge, behaviors, and attitudes about COVID 19 and its related vaccines. Methods: In October 2021, a cross-sectional study with 232 participants was conducted. A standardized interviewer-administered questionnaire was used to collect data. Results: Most respondents in th...
Background: Coronavirus Disease (COVID-19) vaccines have been licensed for usage and have been deliv...
The COVID-19 pandemic has claimed over six million lives and caused significant morbidities globally...
Several vaccines have been approved for use against coronavirus disease (COVID-19) and distributed ...
The vaccination rate against COVID-19 remains low in developing countries due to vaccine hesitancy. ...
COVID-19 is a major public health threat associated with increased disease burden, mortality, and ec...
Vaccines have played a critical role in the response to the COVID-19 pandemic globally, and Tanzania...
The use of vaccines is one of the key tools in reversing the COVID-19 pandemic; however, various rep...
Burgeoning morbidity and mortality due to COVID-19 pandemic including the peaks in outbreaks due to ...
Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by v...
Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by v...
Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by v...
Background As a way of minimising the devastating effects of the coronavirus disease 2019 (COVID-19)...
There is very limited data on the extent and determinants of COVID-19 vaccine hesitancy among adults...
Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by v...
COVID-19 is a major public health threat associated with the increased global burden of infectious d...
Background: Coronavirus Disease (COVID-19) vaccines have been licensed for usage and have been deliv...
The COVID-19 pandemic has claimed over six million lives and caused significant morbidities globally...
Several vaccines have been approved for use against coronavirus disease (COVID-19) and distributed ...
The vaccination rate against COVID-19 remains low in developing countries due to vaccine hesitancy. ...
COVID-19 is a major public health threat associated with increased disease burden, mortality, and ec...
Vaccines have played a critical role in the response to the COVID-19 pandemic globally, and Tanzania...
The use of vaccines is one of the key tools in reversing the COVID-19 pandemic; however, various rep...
Burgeoning morbidity and mortality due to COVID-19 pandemic including the peaks in outbreaks due to ...
Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by v...
Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by v...
Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by v...
Background As a way of minimising the devastating effects of the coronavirus disease 2019 (COVID-19)...
There is very limited data on the extent and determinants of COVID-19 vaccine hesitancy among adults...
Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by v...
COVID-19 is a major public health threat associated with the increased global burden of infectious d...
Background: Coronavirus Disease (COVID-19) vaccines have been licensed for usage and have been deliv...
The COVID-19 pandemic has claimed over six million lives and caused significant morbidities globally...
Several vaccines have been approved for use against coronavirus disease (COVID-19) and distributed ...